Αναζήτηση

This research paper provides an assessment of the legislative proposal for “The European Health Data Space”, including linkages with other EU measures and with Member State rules and laws. It also includes recommendations on further steps needed in order to achieve, facilitate and improve health data sharing, exchange and re-use across the EU.

Quantum technologies could be a game-changer in the digital transformation of health care. By enabling much faster and more complex data analysis, they could open the door to the accelerated discovery and development of novel therapeutics, improved diagnostics and treatments, including for rare and complex diseases, genuinely personalised medicine, and better data-driven health policy planning. However, as is also the case in other sectors, quantum technologies come with risks, particularly to cybersecurity ...

World AIDS Day, proclaimed by the United Nations in 1988, takes place each year on 1 December. The aim is to raise awareness, fight prejudice, encourage progress in prevention, and improve treatment around the world. Although infection with the human immunodeficiency virus (HIV) is preventable, significant HIV transmission remains a challenge to EU Member States' health systems. This year's theme 'Equalize' underlines the urgent need to address the inequalities that are holding back progress in ending ...

This briefing follows up the commitments made by the commissioner since 2019.

Care work provided in homes and institutions is a public good that is under-valued by society. Care workers are more likely to have low earnings and precarious working conditions. About 9 in 10 care workers are women. Most unpaid care work within households is carried out by women. The 'unpaid care penalty' for women in the EU, which is equivalent to the earnings they lost because of this unbalanced distribution of care responsibilities, is estimated to reach €242 billion per year. EU action in the ...

From the beginning of the Covid-19 pandemic in early 2020, and up to mid-April 2020, EU Member States were facing an extraordinary situation that led to the declaration of a health emergency. EU governments gradually took urgent measures to contain the spread of the virus, such as re introduction of border controls in the Schengen area, implementation of temporary travel restrictions, and introduction of sanitary measures. These had vast impact on both mobility and migration. Multiple measures also ...

'This is Europe' – an initiative proposed by the President of the European Parliament, Roberta Metsola – consists of a series of debates with EU leaders to discuss their visions for the future of the European Union. On 5 July 2022, the Prime Minister of Greece, Kyriakos Mitsotakis, was the fourth EU leader to address the Parliament since its Conference of Presidents endorsed the initiative on 28 April 2022. Mr Mitsotakis mentioned EU solidarity frequently, in terms of how it had helped Greece during ...

In recent years, the use of artificial intelligence (AI) in medicine and healthcare has been praised for the great promise it offers, but has also been at the centre of heated controversy. This study offers an overview of how AI can benefit future healthcare, in particular increasing the efficiency of clinicians, improving medical diagnosis and treatment, and optimising the allocation of human and technical resources. The report identifies and clarifies the main clinical, social and ethical risks ...

During the February plenary session, Parliament is expected to debate the final report of its Special Committee on Beating Cancer, and vote on a series of recommendations, calling for specific policy measures in this crucial area of public health.

The European Commission has proposed a regulation on health technology assessment (HTA). HTA is a research-based tool that supports decision-making in healthcare by assessing the added value of a given health technology compared to others. The proposal would provide the basis for permanent EU-level cooperation in four areas. Member States would still be responsible for assessing the non-clinical (economic, ethical, social, etc.) aspects of health technology, and for pricing and reimbursement. While ...